Frank Frantzen
Hoofd Techniek/Wetenschap/O&O bij CardiNor AS
Profiel
Frank Frantzen is currently the Chief Technology Officer at CardiNor AS.
Prior to this, he worked as the Senior Director of Research and Development at Abbott Norge AS and as a Director at Gentian Diagnostics ASA. Frantzen holds a graduate and doctorate degree from the Norwegian University of Science & Technology.
Actieve functies van Frank Frantzen
| Bedrijven | Functie | Begin |
|---|---|---|
CardiNor AS
 CardiNor AS BiotechnologyHealth Technology CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Frank Frantzen
| Bedrijven | Functie | Einde |
|---|---|---|
| GENTIAN DIAGNOSTICS | Directeur/Bestuurslid | 18-12-2023 |
Abbott Norge AS
 Abbott Norge AS Pharmaceuticals: MajorHealth Technology Abbott Norge AS researches, markets, and trades pharmaceuticals and laboratory diagnostics. The company was founded on March 12, 1990 and is headquartered in Fornebu, Norway. | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 |
Opleiding van Frank Frantzen
| Norwegian University of Science & Technology | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GENTIAN DIAGNOSTICS | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Abbott Norge AS
Abbott Norge AS Pharmaceuticals: MajorHealth Technology Abbott Norge AS researches, markets, and trades pharmaceuticals and laboratory diagnostics. The company was founded on March 12, 1990 and is headquartered in Fornebu, Norway. | Health Technology |
CardiNor AS
CardiNor AS BiotechnologyHealth Technology CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway. | Health Technology |
